FibroGen, Inc.
FGEN
$5.75
$0.5911.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.74M | 3.14M | 46.33M | 50.64M | 25.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.74M | 3.14M | 46.33M | 50.64M | 25.36M |
| Cost of Revenue | 9.43M | 1.03M | 27.00M | 39.28M | 57.83M |
| Gross Profit | -6.69M | 2.11M | 19.33M | 11.36M | -32.47M |
| SG&A Expenses | 8.11M | 8.35M | 17.55M | 22.28M | 16.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.53M | 9.37M | 44.56M | 61.56M | 74.55M |
| Operating Income | -14.79M | -6.23M | 1.78M | -10.92M | -49.18M |
| Income Before Tax | -16.76M | -8.66M | -17.07M | -15.81M | -49.04M |
| Income Tax Expenses | 2.00K | 2.00K | 12.00K | -262.00K | 7.00K |
| Earnings from Continuing Operations | -16.77M | -8.67M | -17.08M | -15.54M | -49.05M |
| Earnings from Discontinued Operations | 21.41M | 26.65M | -- | -- | 16.11M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.64M | 17.98M | -17.08M | -15.54M | -32.93M |
| EBIT | -14.79M | -6.23M | 1.78M | -10.92M | -49.18M |
| EBITDA | -14.47M | -5.88M | 2.52M | -10.14M | -48.36M |
| EPS Basic | 1.15 | 4.46 | -4.25 | -3.89 | -8.32 |
| Normalized Basic EPS | -2.58 | -1.20 | 0.23 | -2.47 | -7.74 |
| EPS Diluted | 1.15 | 4.46 | -4.25 | -3.89 | -8.32 |
| Normalized Diluted EPS | -2.58 | -1.20 | 0.23 | -2.47 | -7.74 |
| Average Basic Shares Outstanding | 4.04M | 4.03M | 4.02M | 3.99M | 3.96M |
| Average Diluted Shares Outstanding | 4.04M | 4.03M | 4.02M | 3.99M | 3.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |